Login

Promore Pharma Interview | April 2023 - Jonas Ekblom, CEO, Promore Pharma 00:00:00

Share On Facebook Share On Twitter

Promore Pharma Interview | April 2023 - Jonas Ekblom, CEO, Promore Pharma

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Crafting Success in Healthcare: CEO Insights on Industry Trends and Strategies | A. Hadi Chaudhry, CEO, CareCloud Inc.
00:10:00
Coherent reported that optical fiber firm Lumentum Holdings' CEO discussed the future impacts of cloud computing and artificial intelligence on Schwab Network.
00:10:00
Capella Minerals: Scandinavian and Canadian Exploration Update
00:10:00
Retirement Ready: Navigating the Transition with Erik Fromm | Erik Fromm - Financial Advisor, CSG Capital Partners of Janney Montgomery Scott, LLC
00:10:00
Engages in a broad range of investment activities with flexibility to invest in a wide variety of asset classes|Gregg Lemkau,Chairman,MSD Capital
00:10:00
FTC Solar defines its essence and purpose through its identity and mission | SEAN HUNKLER, PRESIDENT AND CHIEF EXECUTIVE OFFICER, FTC SOLAR INC
00:00:00
Soligenix, Inc.'s interview with Dr. Christopher J. Schaber, Chairman, President, and CEO - Christopher J. Schaber, PhD Chairman, President and Chief Executive Officer, Soligenix Inc
00:10:00
Francisco Reynés Discusses Spain's Energy Transition and Renewable Initiatives | Francisco Reynés, CEO, Naturgy BAN SA.
00:10:00
Proposed Changes to Public Lighting Management in the Federal District | Edison Garcia, CEO, Companhia Energetica de Brasilia.
00:10:00
Revolutionizing Payments: Insights from Jasper Phase III | Collaborative Research by Payments Canada, Bank of Canada, and TMX Group
00:10:00
Elections and Market Trends: Navigating Political Uncertainty with Dimensional Fund Advisors | Mark Gochnour & Jake DeKinder - Dimensional Fund Advisors
00:10:00
Dr. Lijun Zhang Hails China's Tariff Reductions as Model for Asia-Pacific Trade Freedom | Dr. Lijun Zhang, Chairman AT V1 Group Ltd

© 2017 - Neuhu+